Stock Fundamentals

Company Information

Company Name
Becton Dickinson and Company
Sector
Healthcare
Industry
Medical Instruments & Supplies
Exchange
NYSE
ISIN: US0758871091
CIK: 0000010795
CUSIP: 075887109
Currency: USD
Full Time Employees: 60,000
Phone: 201 847 6800
Fiscal Year End: September
IPO Date: Jan 01, 1987
Description:

Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. It operates through Medical Essentials, Connected Care, BioPharma Systems, Interventional and Life Sciences segments. It provides peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular access technology, vascular care and preparation products, needle-free IV connectors and extensions sets, closed-system drug transfer devices, hazardous drug detections, hypodermic syringes and needles, anesthesia needles and trays, enteral syringes, and sharps disposal systems; IV medication safety and infusion therapy delivery systems, medication compounding workflow system, automated medication dispensing and supply management systems, informatics and analytics and pharmacy automation system, and medication inventory optimization and tracking system; hemodynamic monitoring system; and prefillable drug delivery systems. It also offers specimen and blood collection products; automated blood and tuberculosis culturing, molecular testing, and microorganism identification and drug susceptibility, as well as rapid diagnostic assays, microbiology laboratory automation products, and plated media products; and fluorescence-activated cell sorters and analyzers, antibodies and kits, reagent system, and solution for single-cell gene expression analysis, as well as clinical oncology, immunological, and transplantation diagnostic/monitoring reagents and analyzers. It provides hernia and soft tissue repair, biological and bioresorbable graft, biosurgery, and other surgical products; surgical infection prevention, peripheral intervention, and urology and critical care products. The company has a strategic collaboration with ChemoGLO for the advancement of hazardous drug contamination testing in health care

Address:

1 Becton Drive, Franklin Lakes, NJ, United States, 07417-1880

Directors & Officers

Name Title Year Born
Mr. Thomas E. Polen Jr. President, CEO & Chairman 1973
Mr. Michael Garrison Executive VP & President of Medical Segment and BioPharma Systems Segments 1969
Mr. Richard E. Byrd Executive VP & President of Interventional Segment 1968
Mr. Michael C. Feld Executive VP & Chief Revenue Officer 1981
Mr. Vitor Roque Executive VP & CFO 1983
Ms. Elizabeth McCombs Executive VP & CTO 1977
Dr. Joseph M. Smith F.A.C.C, M.D., Ph.D. Senior VP & Chief Scientific Officer NA
Ms. Denise Russell Fleming Executive Vice President & Chief Information Officer 1971
Ms. Lanesha T. Minnix J.D. Executive VP & General Counsel 1975
Carla Burigatto Senior VP & Chief Communications Officer NA

Insider Trading

Date Insider Name Title Transaction Type Shares Price Value
Mar 23, 2026 Ro Khanna N/A Purchase N/A $156.01 N/A
Mar 17, 2026 Kevin Hern N/A Sale N/A $161.64 N/A
Feb 26, 2026 Michael Feld N/A Sale 75.00 $181.84 $13.64K
Feb 18, 2026 Bertram L Scott N/A Sale 953.00 $182.61 $174.03K
Jan 29, 2026 Ro Khanna N/A Purchase N/A $201.27 N/A
Jan 26, 2026 Michael Feld N/A Sale 75.00 $202.73 $15.20K
Jan 23, 2026 Ro Khanna N/A Purchase N/A $201.84 N/A
Jan 15, 2026 Michael David Garrison N/A Sale 1.61K $207.46 $334.01K
Dec 26, 2025 Michael Feld N/A Sale 74.00 $196.08 $14.51K
Dec 17, 2025 Michael David Garrison N/A Sale 629.00 $196.03 $123.30K
Dec 01, 2025 Michael Feld N/A Sale 75.00 $193.36 $14.50K
Nov 10, 2025 Ro Khanna N/A Sale N/A $181.62 N/A
Nov 07, 2025 Bertram L Scott N/A Sale 217.00 $176.58 $38.32K
Nov 03, 2025 Ro Khanna N/A Sale N/A $177.20 N/A
Oct 27, 2025 Michael Feld N/A Sale 57.00 $186.01 $10.60K
Sep 29, 2025 Ro Khanna N/A Purchase N/A $183.85 N/A
Sep 26, 2025 Michael Feld N/A Sale 58.00 $181.03 $10.50K
Sep 10, 2025 Claire Fraser N/A Sale 917.00 $187.50 $171.94K
Aug 08, 2025 Claire Fraser N/A Sale 863.00 $192.30 $165.95K
Aug 04, 2025 Ro Khanna N/A Purchase N/A $178.99 N/A

Institutional Holders

Holder Name Shares Date Reported % Out Value % Change
Vanguard Group Inc 36.68M Dec 31, 2025 13.31% $0.10 13.01%
BlackRock Inc 26.15M Mar 31, 2026 9.49% $0.07 -5.41%
State Street Corp 13.82M Mar 31, 2026 5.02% $0.08 -1.19%
Arnhold & S. Bleichroeder Advisers, LLC 11.93M Mar 31, 2026 4.33% $3.18 2.42%
Amvescap Plc. 10.17M Mar 31, 2026 3.69% $0.24 168.42%
T. Rowe Price Investment Management,Inc. 9.69M Mar 31, 2026 3.52% $1.05 -60.64%
Massachusetts Financial Services Company 9.10M Mar 31, 2026 3.30% $0.75 -4.06%
Geode Capital Management, LLC 7.11M Mar 31, 2026 2.58% $0.07 3.22%
Wellington Management Company LLP 6.62M Mar 31, 2026 2.40% $0.19 24.84%
Franklin Resources Inc 5.36M Mar 31, 2026 1.95% $0.21 2.26%
T. Rowe Price Associates, Inc. 4.42M Mar 31, 2026 1.60% $0.08 3.27%
ClearBridge Advisors, LLC 4.14M Mar 31, 2026 1.50% $0.57 1.17%
Morgan Stanley - Brokerage Accounts 4.02M Mar 31, 2026 1.46% $0.04 19.14%
NORGES BANK 3.78M Dec 31, 2025 1.37% $0.08 -0.25%
JPMorgan Chase & Co 3.57M Mar 31, 2026 1.30% $0.04 0.00%
American Century Companies Inc 3.41M Mar 31, 2026 1.24% $0.28 8.83%
Charles Schwab Investment Management Inc 3.32M Mar 31, 2026 1.21% $0.08 3.90%
Bank of America Corp 2.67M Mar 31, 2026 0.97% $0.03 -5.15%
Northern Trust Corp 2.50M Mar 31, 2026 0.91% $0.05 -0.11%
The Goldman Sachs Group Inc 2.48M Mar 31, 2026 0.90% $0.04 52.55%

Shares Statistics

Shares Outstanding: 275.54M
Shares Float: 274.75M
% Insiders: 40.90%
% Institutions: 9,928.30%
Short % Float: 3.48%

Fund Holdings

Rank Holder Name Shares Held % of Shares Change Date Reported
1 Vanguard Total Stock Mkt Idx Inv 9.07M 3.29% ▲ 0.30% Apr 30, 2026
2 First Eagle Global A 8.06M 2.92% ▲ 0.00% Apr 30, 2026
3 Vanguard 500 Index Investor 7.38M 2.68% ▲ 1.82% Apr 30, 2026
4 Vanguard Mid Cap Index Institutional 6.17M 2.24% ▲ 0.23% Apr 30, 2026
5 T. Rowe Price Capital Appreciation 5.80M 2.10% ▼ 25.34% Mar 31, 2026
6 iShares Core S&P 500 ETF 3.68M 1.34% ▲ 0.29% Apr 30, 2026
7 Fidelity 500 Index 3.64M 1.32% ▼ 0.31% Mar 31, 2026
8 State Street® SPDR® S&P 500® ETF 3.39M 1.23% ▲ 0.33% Apr 30, 2026
9 Putnam Large Cap Value A 3.04M 1.10% ▲ 0.00% Apr 30, 2026
10 Vanguard Equity-Income Inv 2.97M 1.08% ▲ 36.02% Mar 31, 2026

Valuation Metrics

Enterprise Value: $56.51B
Trailing P/E: 25.21
Forward P/E: 10.78

Financial Highlights

Market Cap: $39.80B
EBITDA: $6.16B
P/E Ratio: $25.21
PEG Ratio: $1.11
Book Value: $87.58
Dividend/Share: $4.18
Dividend Yield: 2.88%
Earnings/Share: $5.73
Profit Margin: 5.12%
Operating Margin: 14.74%
ROA (TTM): 4.38%
ROE (TTM): 6.67%
Revenue (TTM): $22.23B
Revenue/Share (TTM): $77.99
Earnings Growth (YOY): 28.60%
Revenue Growth (YOY): 5.20%

Stock Price History

1 Year Price History

2 Years Price History

5 Years Price History

10 Years Price History

Financial Charts

Revenue & Net Income (Yearly)

Revenue & Net Income (Quarterly)

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Yearly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Earnings Per Share (EPS) History

Financial Ratios

Balance Sheet (Yearly)

Financial Ratios

Date Current Ratio Debt/Equity Debt/Assets Interest Coverage Debt/EBITDA
2025-09-30 1.11x 0.76x 0.54x 4.21x 3.87x
2024-09-30 1.17x 0.78x 0.55x 4.54x 4.20x
2023-09-30 1.31x 0.62x 0.51x 4.67x 3.63x
2022-09-30 1.04x 0.64x 0.52x 5.73x 3.67x
2021-09-30 1.33x 0.75x 0.56x 4.80x 4.04x
2020-09-30 1.54x 0.75x 0.56x 1.73x 5.87x
2019-09-30 1.17x 0.92x 0.59x 2.75x 4.77x
2018-09-30 1.03x 1.02x 0.61x 2.14x 5.57x
2017-09-30 5.58x 1.46x 0.66x 2.92x 7.30x
2016-09-30 1.45x 1.51x 0.70x 3.69x 4.48x
2015-09-30 1.38x 1.79x 0.72x 2.89x 6.41x
2014-09-30 2.74x 0.79x 0.59x 11.90x 1.79x
2013-09-30 2.76x 0.79x 0.58x 9.09x 2.15x
2012-09-30 2.69x 1.01x 0.64x 11.54x 1.97x
2011-09-30 2.56x 0.56x 0.54x 19.83x 1.24x
2010-09-30 2.70x 0.31x 0.44x 30.87x 0.81x
2009-09-30 2.61x 0.37x 0.45x 39.36x 0.91x
2008-09-30 2.55x 0.23x 0.38x 42.29x 0.56x
2007-09-30 2.12x 0.27x 0.40x N/A 0.66x
2006-09-30 2.02x 0.36x 0.44x N/A 0.87x
2005-09-30 2.29x 0.39x 0.47x N/A 0.89x
2004-09-30 2.52x 0.40x 0.47x N/A 1.07x
2003-09-30 2.24x 0.45x 0.48x N/A 1.19x
2002-09-30 1.54x 0.50x 0.51x N/A 1.27x
2001-09-30 1.39x 0.53x 0.52x N/A 1.30x
2000-09-30 1.23x 0.72x 0.57x N/A 1.65x
1999-09-30 1.27x 0.36x 0.60x N/A 0.81x
1998-09-30 1.41x 0.24x 0.58x N/A 0.53x
1997-09-30 1.94x 0.10x 0.55x N/A 0.20x
1996-09-30 1.67x 0.17x 0.54x N/A 0.36x
1995-09-30 1.84x 0.15x 0.53x N/A 0.34x
1994-09-30 1.96x 0.12x 0.53x N/A 0.33x
1993-09-30 1.81x 0.14x 0.53x N/A 0.45x
1992-09-30 1.71x 0.18x 0.50x N/A 0.57x
1991-09-30 1.94x 0.10x 0.51x N/A 0.31x
1990-09-30 1.68x 0.14x 0.52x N/A 0.38x
1989-09-30 1.53x 0.18x 0.53x N/A 0.50x
1988-09-30 1.68x 0.20x 0.54x N/A 0.54x
1987-09-30 1.71x 0.21x 0.54x N/A 0.57x
1986-09-30 1.76x 0.19x 0.52x N/A 0.62x
1985-09-30 2.04x 0.09x 0.45x N/A 0.31x

📦 Raw API Data (JSON Explorer)

Watchlist

0

No stocks in watchlist

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about BDX.US!